A recent meta-analysis of 130 preeclampsia prevention trials found some successful strategies but demonstrated the need for more research.
Self-monitoring of blood pressure outside the doctor’s office may help identify women with masked hypertension during pregnancy.
Research study suggests that planned delivery at term (37 weeks) may be an intervention worthy of consideration in women at high-risk for preeclampsia.
This study looked at whether a genome wide analysis study could identify and use maternal DNA variation to predict preeclampsia and gestational hypertension.
This study looked at whether messenger RNA markers in the blood stream could help identify patients at risk of developing preterm or early-onset preeclampsia.
Based on limited data, pravastatin use during pregnancy does not appear to have any long-term adverse effects on children. his information will be useful for gaining approval for larger studies to see if pravastatin is actually useful in preventing...
In this paper, researchers describe how they developed an ionized lipid nanoparticle that is taken into mouse placental cells to increase VEGF.
Identifying the healthful behaviors that lower the risk for a hypertensive disorder of pregnancy can help develop recommendations and prevention programs to support lowering pregnant women’s risk for developing a hypertensive disorder of pregnancy.
Genetic research over the past 10 years has shown a difference in gene expression in single-cells from placentas of pregnancies with preeclampsia compared to normotensive placentas.
Researchers asked if microRNAs that are linked to cardiovascular disease in non-pregnant people could help predict HELLP syndrome.
This study suggests that women of different BMI classes might have distinct risk profiles for preeclampsia.
Research is being done to make a medicine that can cure preeclampsia a reality. In this article, researchers asked: what are the candidate medicines being studied currently to prevent or treatment preeclampsia?